What's new in musculoskeletal oncology

Journal of Bone and Joint Surgery

Volumn 87, Issue 6, 2005, Pages 1400-1409

  Weber, Kristy L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; BENIGN TUMOR; BONE DESTRUCTION; BONE METASTASIS; BONE TUMOR; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SURVIVAL; CANCER THERAPY; ENDOPROSTHESIS; EVIDENCE BASED MEDICINE; HUMAN; LIMB SALVAGE; MALIGNANT NEOPLASTIC DISEASE; MUSCULOSKELETAL DISEASE; ONCOLOGY; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA;

EID: 19944419133     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.E.00257     Document Type: Review

References (53)

1. Ozaki T, Wai D, Schafer KL, Lindner N, Bocker W, Winkelmann W, Dockhorn-Dworniczak B, Poremba C. Comparative genomic hybridization in cartilaginous tumors. Anticancer Res. 2004;24:1721-5.
2. Martin JA, DeYoung BR, Gitelis S, Weydert JA, Klingelhutz AJ, Kurriger G, Buckwalter JA. Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy. Clin Orthop Relat Res. 2004;426:117-24.
3. Tiet TD, Hopyan S, Nadesan P. Bell RS, Wunder J, Alman B. Hedgehog signaling regulates proliferation in chondrosarcoma: implication for novel therapy. Presented as a poster exhibit at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2004 Mar 10-14; San Francisco, CA.
4. Leerapun T, Sim FH, Hugate RR, Frick MA, Lymp JF, Sundaram M, Inwards C, Scully SP. Outcomes following intralesional curettage versus wide resection of low grade chondrosarcoma. AAOS Proceedings 2005;632.
5. Schwab JH, Jacofsky DJ, Wenger D, Unni KK, Sim FH. Recurrent grade I chondrosarcoma of the long bones. AAOS Proceedings. 2005:631.
6. Fong YC, Pairolero PC, Sim FH, Cha SS, Blanchard CL, Scully SP. Chondrosarcoma of the chest wall: a retrospective clinical analysis. Clin Orthop Relat Res. 2004;427:184-9.
7. Donati D, El Ghoneimy A, Bertoni F, DiBella C, Mercuri M. Surgical treatment and outcome of primary and recurrent pelvic chondrosarcoma. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2004 Mar 10-14; San Francisco, CA.
8. Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH, Scully SP. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am. 2004;86:2412-8.
9. Mankin HJ. Poor survival for patients with Paget's sarcoma. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2005 Feb 23-27; Washington, DC.
10. Casas-Ganem J, Healey JH. Advances that are changing the diagnosis and treatment of malignant bone tumors. Curr Opin Rheumatol. 2005;17:79-85.
11. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004;4:45.
12. Thomas DM, Johnson SA, Sims NA, Trivett MK, Slavin JL, Rubin BP, Waring P, McArthur GA, Walkley CR, Holloway AJ, Diyagama D, Grim JE, Clurman BE, Bowtell DD, Lee JS, Gutierrez GM, Piscopo DM, Carty SA, Hinds PW. Terminal osteoblast differentiation, mediated by RUNX2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol. 2004;167:925-34.
13. Bacci G, Longhi A, Ferrari S, Briccoli A, Donati D, De Paolis M, Versari M. Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years. Tumori. 2004;90:478-84.
14. Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004;9:422-41.
15. Benini S, Manara MC, Cerisano V, Perdichizzi S, Strammiello R, Serra M, Picci P, Scotlandi K. Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospects. Int J Cancer. 2004;108:358-66.
16. Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ, Tsokos M, Kontny HU, Mackall CL. Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma. Cancer Res. 2004;64:8349-56.
17. Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694-701.
18. Miser JS, Krailo MD, Tarbell NJ, Link MP Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide - a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol. 2004;22:2873-6.
19. Hosalkar HS, Henderson KM, Weiss A, Donthineni R, Lackman RD. Chemotherapy for bone sarcoma does not affect fertility rates or childbirth. Clin Orthop Relat Res. 2004;428:256-60. Erratum in: Clin Orthop Relat Res. 2004;429:352.
20. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kutschik M, Werner M,Winkelmann W, Zoubeck A, Jurgens H, Winkler K. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-90.
21. Saeter G, Elomaa I, Wahlqvist Y, Alvegard TA, Wiebe T, Monge O, Forrestier E, Solheim OP. Prognostic factors in bone sarcomas. Acta Orthop Scand Suppl. 1997;273:156-60.
22. Ganjavi H, Gee M, Narendran A, Freedman MH, Malkin D. Adenovirusmediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin. Cancer Gene Ther. 2005;12:397-406.
23. Worden FP, Taylor JM, Biermann JS, Sondak VK, Leu KM, Chugh R, McGinn CJ, Zalupski MM, Baker LH. Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma. J Clin Oncol. 2005;23:105-12.
24. Cormier JN, Huang X, Xing Y, Thall PF, Wang X, Benjamin RS, Pollock RE, Antonescu CR, Maki RG, Brennan MF, Pisters PW. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol. 2004;22:4567-74.
25. Schuetze SM, Rubin BP, Vernon C, Hawkins DS, Bruckner JD, Conrad EU 3rd, Eary JF. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer. 2005;103:339-48.
26. DeLaney TF. Optimizing radiation therapy and post-treatment function in the management of extremity soft tissue sarcoma. Curr Treat Options Oncol. 2004;5:463-76.
27. Holt GE, Griffin AM, Pintilie M, Wunder JS, Catton C, O'Sullivan B, Bell RS. Fractures following radiotherapy and limb-salvage surgery for lower extremity softtissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am. 2005;87:315-9.
28. Yandow SM, Lundeen GA, Scott SM, Coffin C. Autogenic bone marrow injections as a treatment for simple bone cyst. J Pediatr Orthop. 1998;18:616-20.
29. Gitelis S, Virkus W, Anderson D, Piasecki P, Yao TK. Functional outcomes of bone graft substitutes for benign bone tumors. Orthopedics. 2004;27(1 Suppl):141-4.
30. Aponte-Tinao LA, Muscolo DL, Ayerza MA, Abalo E, Bongiovanni S. Cement filling compared with bone allografting after curettage of giant-cell tumor of the knee. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2004 Mar 10-14; San Francisco, CA.
31. Collins MT, Kushner H, Reynolds JC, Chebli C, Kelly MH, Gupta A, Brillante B, Leet AI, Riminucci M, Robey PG, Bianco P, Wientroub S, Chen CC. An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res. 2005;20:219-26.
32. Porter DE, Lonie L, Fraser M, Dobson-Stone C, Porter JR, Monaco AP, Simpson AH. Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br. 2004;86:1041-6.
33. Bassett MD, Schuetze SM, Disteche C, Norwood TH, Swisshelm K, Chen X, Bruckner J, Conrad EU 3rd, Rubin BP. Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities: the role of cytogenetics in classification and prognostication. Cancer. 2005;103:409-16.
34. Guise TA, Mohammad KS. Endothelins in bone cancer metastases. Cancer Treat Res. 2004;118:197-212.
35. Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET. Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. Cancer Res. 2003;63:7883-90.
36. Hong J, Cabe GD, Tedrow JR, Hipp JA, Snyder BD. Failure of trabecular bone with simulated lytic defects can be predicted non-invasively by structural analysis. J Orthop Res. 2004;22:479-86.
37. Schneiderbauer MM, von Knoch M, Schleck CD, Harmsen WS, Sim FH, Scully SP. Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Joint Surg Am. 2004;86:1684-9.
38. Jacofsky DJ, Haidukewych GJ, Zhang H, Sim FH. Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip. Clin Orthop Relat Res. 2004;427:52-6.
39. Masala S, Lunardi P, Fiori R, Liccardo G, Massari F, Ursone A, Simonetti G. Vertebroplasty and kyphoplasty·in the treatment of malignant vertebral fractures. J Chemother. 2004;16 Suppl 5:30-3.
40. Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, Wong GY, Sloan JA, Novotny PJ, Petersen IA, Beres RA, Regge D, Capanna R, Saker MB, Gronemeyer DH, Gevargez A, Ahrar K, Choti MA, de Baere TJ, Rubin J. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22:300-6.
41. Gerszten PC, Welch WC. Cyberknife radiosurgery for metastatic spine tumors. Neurosurg Clin N Am. 2004;15:491-501.
42. DeGroot H, Donati D, Di Liddo M, Gozzi E, Mercuri M. The use of cement in osteoarticular allografts for proximal humeral bone tumors. Clin Orthop Relat Res. 2004;427:190-7.
43. Ayerza MA, Muscolo DL, Aponte-Tinao LA. Unicompartmental osteoarticular allografts of the knee: survival analysis and complications. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2005 Feb 23-27; Washington, DC.
44. Muscolo DL, Ayerza MA, Aponte-Tinao L, Ranalletta M, Abalo E. Intercalary femur and tibia segmental allografts provide an acceptable alternative in reconstructing tumor resections. Clin Orthop Relat Res. 2004;426:97-102.
45. Muscolo DL, Ayerza MA, Aponte-Tinao L, Ranalletta M. Partial epiphyseal preservation and intercalary allograft reconstruction in high-grade metaphyseal osteosarcoma of the knee. J Bone Joint Surg Am. 2004;86:2686-93.
46. Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J, Zhang X, Rubery PT, Rabinowitz J, Samulski RJ, Nakamura T, Soballe K, O'Keefe RJ, Boyce BF, Schwarz EM. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med. 2005;11:291-7.
47. Innocenti M, Delcroix L, Manfrini M, Ceruso M, Capanna R. Vascularized proximal fibular epiphyseal transfer for distal radial reconstruction. J Bone Joint Surg Am. 2004;86:1504-11.
48. Unwin P, Blunn G. Osseointegrated extracortical bony bridging of cemented intramedullary stemmed distal femoral replacements. MSTS Abstracts. 2004;59.
49. Griffin AM, Parsons JA, Davis AM, Bell RS, Wunder JS. Outcome following endoprosthetic replacement of the distal femur and proximal tibia: comparion of results and analysis of failures. MSTS Abstracts. 2004;56.
50. Ogilvie CM, Wunder JS, Ferguson PC, Griffin AM, Bell RS. Functional outcome of endoprosthetic proximal femoral replacement. Clin Orthop Relat Res. 2004;426:44-8.
51. Dickey ID, Reach JS, Talac R, Zobitz ME, Adams JE, Lewallen DG, Scully SR Tendon reattachment with a foam metal prosthesis: an in-vivo canine study. MSTS Abstracts. 2004;47.
52. Gitelis S, Neel MD, Wilkins RM, Rao BN, Kelly CM, Yao TK. The use of a closed expandable prosthesis for pediatric sarcomas. Chir Organi Mov. 2003;88:327-33.
53. Hufner T, Kfuri M Jr, Galanski M, Bastian L, Loss M, Pohlemann T, Krettek C. New indications for computer-assisted surgery: tumor resection in the pelvis. Clin Orthop Relat Res. 2004;426:219-25.